Forest Laboratories is a developer of drugs products for central nervous system, cardiovascular, gastrointestinal, respiratory and anti-infective.
Business Model:
Revenue: $3.6B
Employees: 5,001-10,000
Forest Laboratories was acquired by
Actavis.
The acquisition happend on 2014-02-18.
Details of the transaction were not public
Address: 909 3rd Ave
City: New York
State: NY
Zip: 10022
Country: US
Forest Laboratories is a developer of drugs products for central nervous system, cardiovascular, gastrointestinal, respiratory and anti-infective.
Contact Phone:
+12124217850
Contact Email:
Listed Exchange:
NYSE
IPO Date:
1/13/1978
Ticker Symbol:
FRX
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
5/2013 | Trevena | Series C | 60M |
10/2012 | moksha8 Pharmaceuticals | Funding Round | 125M |
6/2010 | TransTech Pharma | Venture Round | 50M |
5/2013 | Trevena | Series C | 0 |
10/2012 | moksha8 Pharmaceuticals | Funding Round | 0 |
6/2010 | TransTech Pharma | Venture Round | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|---|---|
4/2014 | Furiex Pharmaceuticals | |
1/2014 | Aptalis Pharma | |
2/2011 | Clinical Data | |
12/2006 | Cerexa Inc. |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|